Explore GEN family of websites, social media experiences, blogs and more.

Unleashing ideas.
Strengthening startups.

Back to search results
    Date submitted
  • 26-Sep-2017



In an era of precision medicine, diagnostics able to unravel healthcare inefficiencies and the mysteries of patient outcomes will emerge as the new therapeutics. With this creed, Atantares Corp.

(“atantares”) strength lies in designing and producing microsystem technologies tailored for the next generation of smart, precision medical applications.

Drawing on the precision and economics of semiconductor manufacturing born and bred at MIT, coupled with thought leadership who understand and help define clinical trajectories, our goal is to provide the global healthcare sector with diagnostic tools characterized by cost-effective, best-in-class performance and packaged in a point-of-care (POC) footprint. End-user convenience, reduced payer costs, and improved performance are incorporated into the depths of our designs allowing rapid market entry and early revenue alongside established clinical standards and market giants. This entry strategy reduces early investor-risk while establishing industry presence and the game-changing technologies needed to achieve our vision. We want to revolutionize medical practice though applied precision diagnostics and provide investors with explosive potential.

Additional Questions

Investor questions have not yet been answered for this business